SCOTTSDALE, Ariz., April 21, 2015 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCBB:AVDX), a diagnostic company with a primary focus on the commercialization of a proprietary microarray-based diagnostic test for the early detection of ovarian cancer called OvaDx® is pleased to announce that it has retained the professional legal services of Sichenzia Ross Freidman Ference LLP (“SRFF”) as the Company’s general corporate counsel.
Gregg Linn, Avant’s President and Chief Executive Officer stated, “We are proud to have retained the services of one of the nation’s leading securities and corporate law firms in the United States. Sichenzia Ross Freidman Ference LLP’s core competency in nurturing microcap development stage companies, like Avant Diagnostics, will definitely provide Avant a strong platform for growth.”
Sichenzia Ross Freidman Ference LLP founding partner Gregory Sichenzia said that he was delighted to be working with Gregg Linn and the talented management team at Avant.
About Avant Diagnostics, Inc.
Avant is a medical diagnostic technology company that specializes in first large panel biomarker screening. Our first test, OvaDx® detects for pre-symptomatic ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Pre-clinical research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA 510K approval, Avant Diagnostics intends to sell or license OvaDx® as a diagnostic test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. Avant intends to utilize its public company stage to expand its portfolio of diagnostic tests in the future.
About Sichenzia Ross Friedman Ference LLP
Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn and our Twitter page: @SRFFLLP
Safe Harbor Statement
We have identified forward-looking statements by using words such as “expect”, “believe”, and “should”. Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company’s Form 8-K for the fiscal year ended September 30, 2014 and in Form 10-Q for the quarterly period ended December 31, 2014.
CONTACT: Company Contacts: Gregg Linn, President/CEO 480-478-6660 glinn@avantdiagnostics.com Steven Scott 617-448-1300 sscott@scottgrp.com
Help employers find you! Check out all the jobs and post your resume.
